Literature DB >> 3486091

Costing acute myocardial infarction in New South Wales, Australia, based on incidence rather than prevalence methods.

G Goldstein, R Reznik, H Lapsley, Y Cass.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3486091     DOI： 10.1111/j.1753-6405.1986.tb00076.x

Source DB:  PubMed          Journal:  Community Health Stud        ISSN： 0314-9021


× No keyword cloud information.
  3 in total

1.  Cost-of-illness studies: a guide to critical evaluation.

Authors:  Allison Larg; John R Moss
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

Review 2.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

Review 3.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.